European Commission weak on hazardous chemicals- Lynn Boylan MEP
Dublin Sinn Féin MEP Lynn Boylan has spoken in the EU Parliament plenary session in Strasbourg last night about latest impact of the European Commission’s cosiness with corporate Europe.
The focus of the speech were Endocrine Disrupting Chemicals (EDCs), which are predominantly man-made and are found in materials such as pesticides, metals, additives or contaminants in food, and personal care products.
Ms Boylan said:
According to the latest leak from within the European Commission, an EU paper on endocrine disruptors was due to propose criteria for categorisations of EDCs which would have led to an EU ban on a range of hazardous substances.
However thanks to heavy lobbying from the major players in the chemical industry, who stand to lose big profits on these chemicals, the report has mysteriously yet to surface.
Instead, the European Commission is proposing to release an impact assessment in 2016.
It is disheartening to hear another story of the Commission bending to the will of its corporate bedfellows instead of implementing rigorous regulation to protect consumers and the environment from harmful substances.
There is no excuse for any delay – there is plenty of scientific evidence to support the immediate suspension of the use of certain harmful substances. A view, which is also held by certain influential Member States.”
The Sinn Féin MEP continued stating that:
“Given that EDCs are used routinely in everyday household items such as household toiletries, cosmetics, food containers, plastics and pesticides to name but a few, it is extremely urgent that the precautionary principle is upheld and action is not postponed as the Commission plans but is taken now.
These chemicals have been linked to a wide range of diseases and conditions such as; foetal abnormalities, infertility, autism, diabetes and hormonal cancers such as breast and testicular.
This Frankenstein list of health costs is only compounded when we consider the staggering economic cost of EDC exposure.
Every year of inaction on EDCs means massive increased costs to health systems and a great risk to our consumers. The Commission has once again proved itself to hold corporate interests in higher regard than consumer health.”